Claims for Patent: 7,799,954

Summary for Patent: 7,799,954

Title:	Dicarbonyl derivatives and methods of use
Abstract:	Derivatives of dicarbonyl compounds having antitumor and antibiotic activity which can be used as anticancer agents.
Inventor(s):	Tao; Chunlin (Los Angeles, CA), Wang; Qinwei (Alhambra, CA), Trieu; Vuong (Calabasas, CA), Desai; Neil (Los Angeles, CA), Soon-Shiong; Patrick (Los Angeles, CA)
Assignee:	Abraxis BioScience, LLC (Los Angeles, CA)
Application Number:	11/939,909
Patent Claims:	1. A compound or pharmaceutically acceptable salt thereof having the formula (I) ##STR00251## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, and R.sub.6 are independently a hydrogen atom or an alkyl, alkenyl, alkynyl, or aryl comprising 1 to 30 carbon atoms and which is unsubstituted or substituted by at least one of hydroxy, cyano, mercapto, halogen, --OR.sub.7, SR.sub.7, --NR.sub.7R.sub.8, --CONR.sub.7R.sub.8, or --OCONR.sub.7R.sub.8, wherein R.sub.7 and R.sub.8 are a hydrogen atom; an alkyl, alkenyl, or alkynyl comprising 1 to 20 carbon atoms; a cyclic or heterocyclic group comprising 5 or 6 ring atoms of which from 0 to 3 are nitrogen and/or oxygen and/or sulphur hetero-atoms, said cyclic or heterocyclic group being unsubstituted or substituted by at least one of hydroxy, cyano, mercapto, halogen, or an alkyl group comprising 1 to 6 carbon atoms; and X and Y are respectively O, NR.sub.7 or S, wherein when X and Y are O, and if R.sub.2, R.sub.4 are hydrogen, R.sub.1-R.sub.3 or both R.sub.1-R.sub.3 and R.sub.5-R.sub.6 form a cyclic or an acyclic alkenyl; when X and Y are O, and if R.sub.2, R.sub.4 form a single bond, R.sub.1 is ##STR00252## wherein Ar is an aryl or heteroaryl. 2. The compound of claim 1, wherein X and Y are O, and R.sub.6 is --NR.sub.7R.sub.8. 3. The compound of claim 1, wherein X and Y are O. 4. The compound of claim 1, wherein the compound has the following formula: ##STR00253## 5. The compound of claim 4, wherein R.sub.7 and R.sub.8 are C.sub.1-C.sub.10 alkyl and C.sub.6-C.sub.10 aryl, respectively. 6. The compound of claim 1, wherein the compound has the following formula: ##STR00254## 7. The compound of claim 6, wherein R.sub.7 and R.sub.8 are C.sub.1-C.sub.10 alkyl and C.sub.6-C.sub.10 aryl, respectively. 8. The compound of claim 7, wherein X is H, 3-OMe, 4-OMe, or 3,4-di-OMe. 9. A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier. 10. The pharmaceutical composition of claim 9, wherein the composition is suitable for delivery via routes of administration selected from the group consisting of oral and parenteral administration. 11. The pharmaceutical composition of claim 10, wherein said composition is suitable for oral delivery and further comprises one or more ingredients selected from the group consisting of a diluent, an edible carrier, a binder, an excipient, a disintegrating agent, a lubricant, a glidant, and a sweetening agent. 12. The pharmaceutical composition of claim 10, wherein said composition is suitable for parenteral delivery and comprises one or more ingredients selected from the group consisting of a sterile diluent, antimicrobial agents, antioxidants, buffers, and tonicity adjusting agents. 13. A pharmaceutical composition comprising the compound of claim 2 and a pharmaceutically acceptable carrier. 14. The pharmaceutical composition of claim 13, wherein the composition is suitable for delivery via routes of administration selected from the group consisting of oral, parenteral, intravenous, and combinations thereof. 15. The pharmaceutical composition of claim 14, wherein said composition is suitable for oral delivery and further comprises one or more ingredients selected from the group consisting of a diluent, an edible carrier, a binder, an excipient, a disintegrating agent, a lubricant, a glidant, and a sweetening agent. 16. The pharmaceutical composition of claim 14, wherein said composition is suitable for parenteral delivery and comprises one or more ingredients selected from the group consisting of a sterile diluent, antimicrobial agents, antioxidants, buffers, and tonicity adjusting agents. 17. A pharmaceutical composition comprising the compound of claim 3 and a pharmaceutically acceptable carrier. 18. The pharmaceutical composition of claim 17, wherein the composition is suitable for delivery via routes of administration selected from the group consisting of oral, parenteral, intravenous, and combinations thereof. 19. The pharmaceutical composition of claim 18, wherein said composition is suitable for oral delivery and further comprises one or more ingredients selected from the group consisting of a diluent, an edible carrier, a binder, an excipient, a disintegrating agent, a lubricant, a glidant, and a sweetening agent. 20. The pharmaceutical composition of claim 18, wherein said composition is suitable for parenteral delivery and comprises one or more ingredients selected from the group consisting of a sterile diluent, antimicrobial agents, antioxidants, buffers, and tonicity adjusting agents. 21. A pharmaceutical composition comprising the compound of claim 4 and a pharmaceutically acceptable carrier. 22. The pharmaceutical composition of claim 21, wherein the composition is suitable for delivery via routes of administration selected from the group consisting of oral and parenteral administration. 23. The pharmaceutical composition of claim 22, wherein said composition is suitable for oral delivery and further comprises one or more ingredients selected from the group consisting of a diluent, an edible carrier, a binder, an excipient, a disintegrating agent, a lubricant, a glidant, and a sweetening agent. 24. The pharmaceutical composition of claim 22, wherein said composition is suitable for parenteral delivery and comprises one or more ingredients selected from the group consisting of a sterile diluent, antimicrobial agents, antioxidants, buffers, and tonicity adjusting agents. 25. A pharmaceutical composition comprising the compound of claim 5 and a pharmaceutically acceptable carrier. 26. The pharmaceutical composition of claim 25, wherein the composition is suitable for delivery via routes of administration selected from the group consisting of oral and parenteral administration. 27. The pharmaceutical composition of claim 26, wherein said composition is suitable for oral delivery and further comprises one or more ingredients selected from the group consisting of a diluent, an edible carrier, a binder, an excipient, a disintegrating agent, a lubricant, a glidant, and a sweetening agent. 28. The pharmaceutical composition of claim 26, wherein said composition is suitable for parenteral delivery and comprises one or more ingredients selected from the group consisting of a sterile diluent, antimicrobial agents, antioxidants, buffers, and tonicity adjusting agents. 29. A pharmaceutical composition comprising the compound of claim 6 and a pharmaceutically acceptable carrier. 30. The pharmaceutical composition of claim 29, wherein the composition is suitable for delivery via routes of administration selected from the group consisting of oral and parenteral administration. 31. The pharmaceutical composition of claim 30, wherein said composition is suitable for oral delivery and further comprises one or more ingredients selected from the group consisting of a diluent, an edible carrier, a binder, an excipient, a disintegrating agent, a lubricant, a glidant, and a sweetening agent. 32. The pharmaceutical composition of claim 30, wherein said composition is suitable for parenteral delivery and comprises one or more ingredients selected from the group consisting of a sterile diluent, antimicrobial agents, antioxidants, buffers, and tonicity adjusting agents. 33. A pharmaceutical composition comprising the compound of claim 7 and a pharmaceutically acceptable carrier. 34. The pharmaceutical composition of claim 33, wherein the composition is suitable for delivery via routes of administration selected from the group consisting of oral, and parenteral administration. 35. The pharmaceutical composition of claim 34, wherein said composition is suitable for oral delivery and further comprises one or more ingredients selected from the group consisting of a diluent, an edible carrier, a binder, an excipient, a disintegrating agent, a lubricant, a glidant, and a sweetening agent. 36. The pharmaceutical composition of claim 34, wherein said composition is suitable for parenteral delivery and comprises one or more ingredients selected from the group consisting of a sterile diluent, antimicrobial agents, antioxidants, buffers, tonicity and adjusting agents. 37. A pharmaceutical composition comprising the compound of claim 8 and a pharmaceutically acceptable carrier. 38. The pharmaceutical composition of claim 37, wherein the composition is suitable for delivery via routes of administration selected from the group consisting of oral and parenteral administration. 39. The pharmaceutical composition of claim 38, wherein said composition is suitable for oral delivery and further comprises one or more ingredients selected from the group consisting of a diluent, an edible carrier, a binder, an excipient, a disintegrating agent, a lubricant, a glidant, and a sweetening agent. 40. The pharmaceutical composition of claim 38, wherein said composition is suitable for parenteral delivery and comprises one or more ingredients selected from the group consisting of a sterile diluent, antimicrobial agents, antioxidants, buffers, tonicity and adjusting agents. 41. The compound of claim 8, wherein X is H. 42. The compound of claim 8 wherein X is 3-OMe. 43. The compound of claim 8 wherein X is 4-OMe. 44. The compound of claim 8 wherein X is 3, 4-di-OMe. 45. A pharmaceutical composition comprising the compound of claim 41 and a pharmaceutically acceptable carrier. 46. The pharmaceutical composition of claim 45, wherein the composition is suitable for delivery via routes of administration selected from the group consisting of oral and parenteral administration. 47. The pharmaceutical composition of claim 46, wherein said composition is suitable for oral delivery and further comprises one or more ingredients selected from the group consisting of a diluent, an edible carrier, a binder, an excipient, a disintegrating agent, a lubricant, a glidant, and a sweetening agent. 48. The pharmaceutical composition of claim 46, wherein said composition is suitable for parenteral delivery and comprises one or more ingredients selected from the group consisting of a sterile diluent, antimicrobial agents, antioxidants, buffers, tonicity and adjusting agents. 49. A pharmaceutical composition comprising the compound of claim 42 and a pharmaceutically acceptable carrier. 50. The pharmaceutical composition of claim 49, wherein the composition is suitable for delivery via routes of administration selected from the group consisting of oral and parenteral administration. 51. The pharmaceutical composition of claim 50, wherein said composition is suitable for oral delivery and further comprises one or more ingredients selected from the group consisting of a diluent, an edible carrier, a binder, an excipient, a disintegrating agent, a lubricant, a glidant, and a sweetening agent. 52. The pharmaceutical composition of claim 50, wherein said composition is suitable for parenteral delivery and comprises one or more ingredients selected from the group consisting of a sterile diluent, antimicrobial agents, antioxidants, buffers, tonicity and adjusting agents. 53. A pharmaceutical composition comprising the compound of claim 43 and a pharmaceutically acceptable carrier. 54. The pharmaceutical composition of claim 53, wherein the composition is suitable for delivery via routes of administration selected from the group consisting of oral and parenteral administration. 55. The pharmaceutical composition of claim 54, wherein said composition is suitable for oral delivery and further comprises one or more ingredients selected from the group consisting of a diluent, an edible carrier, a binder, an excipient, a disintegrating agent, a lubricant, a glidant, and a sweetening agent. 56. The pharmaceutical composition of claim 54, wherein said composition is suitable for parenteral delivery and comprises one or more ingredients selected from the group consisting of a sterile diluent, antimicrobial agents, antioxidants, buffers, tonicity and adjusting agents. 57. A pharmaceutical composition comprising the compound of claim 44 and a pharmaceutically acceptable carrier. 58. The pharmaceutical composition of claim 57, wherein the composition is suitable for delivery via routes of administration selected from the group consisting of oral and parenteral administration. 59. The pharmaceutical composition of claim 58, wherein said composition is suitable for oral delivery and further comprises one or more ingredients selected from the group consisting of a diluent, an edible carrier, a binder, an excipient, a disintegrating agent, a lubricant, a glidant, and a sweetening agent. 60. The pharmaceutical composition of claim 58, wherein said composition is suitable for parenteral delivery and comprises one or more ingredients selected from the group consisting of a sterile diluent, antimicrobial agents, antioxidants, buffers, tonicity and adjusting agents.

Details for Patent 7,799,954

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2026-11-17